ASGE Masterclass: Capsule Quest – Journey Through the Future of GI Diagnostics (Virtual)

Video Transcription

Video Summary

The clinical utility of MCCE (Magnetically Controlled Capsule Endoscopy) could expand, serving as an initial screening tool for abnormalities that could lead to a traditional endoscopy for further evaluation if needed. This technology is already used in countries like China to screen for gastric cancer, similar to mammograms in the U.S. AI-assisted capsule endoscopy may initially require additional review time, but can enhance diagnostic accuracy with experience. The adoption of technologies like OMAM and ANX is viewed as disruptive, challenging larger companies like Medtronic. Procedure costs and reimbursement dynamics significantly influence adoption in healthcare settings.

Keywords

Magnetically Controlled Capsule Endoscopy

AI-assisted diagnostics

gastric cancer screening

disruptive medical technology

healthcare reimbursement